{"id":13464,"date":"2025-02-20T14:45:44","date_gmt":"2025-02-20T12:45:44","guid":{"rendered":"https:\/\/jacyprus.org\/?p=13464"},"modified":"2025-02-20T14:45:44","modified_gmt":"2025-02-20T12:45:44","slug":"towards-innovation-in-healthcare-beyond-pitching-day","status":"publish","type":"post","link":"https:\/\/jacyprus.org\/en\/towards-innovation-in-healthcare-beyond-pitching-day\/","title":{"rendered":"Towards Innovation in Healthcare: Beyond Pitching Day"},"content":{"rendered":"

Marking the Transition to the \u2018\u2019Test & Development\u2019\u2019 Phase<\/strong><\/p>\n

The Beyond Pitching Day<\/strong>, held on the 4th of February at the Novartis Cyprus premises<\/strong>, marked an important milestone in the programme, as teams concluded the Educational Phase<\/strong> and presented their healthcare business ideas<\/strong> to a distinguished jury committee.<\/p>\n

The jury committee featured esteemed professionals from various industries, including Jevgenija Kirillova \u2013 CFO Novartis Cyprus & Malta, \u00a0Andri Andreou \u2013 External Affairs Manager, Novartis Cyprus, Marilena Paraskeva \u2013 Head of the Funding Programmes Department, Research and Innovation Foundation, Petroula Gerasimou \u2013 Molecular Diagnostic Laboratory Supervisor, Karaiskakio Foundation, Michalis Strouthos \u2013 Co-Founder & CEO, Cocoon Creations & Crew, and George Pelekanos \u2013 Website Administrator, Marketing & CX, Bank of Cyprus.<\/p>\n

After an inspiring round of pitches and valuable feedback from the jury committee, the teams have now advanced to the Test and Development Phase<\/strong>, where they will receive an initial funding<\/strong> to start building their Minimum Viable Product (MVP)<\/strong>.<\/p>\n

Beyond Pitching Day was a testament to the innovation, dedication, and entrepreneurial spirit of the participants. As teams enter the Test and Development Phase, they are one step closer to bringing their ideas to life. In this phase, with the support of Junior Achievement (JA) Cyprus, the focus will be on refining business models and developing prototypes.<\/p>\n

The program is conducted with the sponsorship of Novartis Pharma Services Inc. Cyprus<\/strong> and the support of partner organizations: Cyprus Institute of Neurology and Genetics, Cocoon Creations, CYENS Centre of Excellence, Cyprus Federation of Patients\u2019 Associations (CyFPA), Cyprus Oncology Society, Cyprus Seeds, Gravity Ventures, Idea Innovation Centre, Karaiskakio Foundation and Kinisis Ventures.<\/p>\n

Junior Achievement Cyprus is member of the global non-profit organization JA Worldwide, specializing in education on entrepreneurship, financial literacy, and the job market. More information can be found at www.jacyprus.org<\/a>.<\/p>\n

Novartis AG is a Swiss multinational, innovative pharmaceutical company headquartered in Basel, Switzerland. Novartis Pharma Services Inc. Cyprus is the local representative and has been operating in the country since 2009. Our purpose is to reimagine medicine<\/strong> to improve and extend people’s lives<\/strong>. We use innovative science and technology to address some of society’s most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible. \u00a0In 2024, our medicines reached 296 million patients around the world.\u00a0 More information can be found at https:\/\/www.novartis.com\/<\/a> \u00a0or the local Facebook page https:\/\/www.facebook.com\/NovartisCyprus<\/a><\/p>\n

For inquiries or more information, please contact us at eleni.tovletian@jacyprus.org<\/a><\/p>\n\n